发明名称 |
RNA interference for the treatment of gain-of-function disorders |
摘要 |
The present invention relates to the discovery of an effective treatment for a variety of gain-of-function diseases, in particular, Huntington's disease (HD). The present invention utilizes RNA Interference technology (RNAi) against polymorphic regions in the genes encoding various gain-of-function mutant proteins resulting in an effective treatment for the gain-of-function disease. |
申请公布号 |
US9434943(B2) |
申请公布日期 |
2016.09.06 |
申请号 |
US201414161266 |
申请日期 |
2014.01.22 |
申请人 |
University of Massachusetts |
发明人 |
Aronin Neil;Zamore Phillip D. |
分类号 |
C12N15/113;C12N15/11 |
主分类号 |
C12N15/113 |
代理机构 |
Lathrop & Gage, LLP. |
代理人 |
Lathrop & Gage, LLP. ;Velema, Esq. James H. |
主权项 |
1. A composition for treating a subject having or at risk for Huntington's disease caused by a mutation within the htt gene encoding a gain-of-function mutant huntingtin protein, comprising:
a vector that expresses an effective amount of an siRNA or an shRNA targeting a non-disease causing heterozygous single nucleotide polymorphism (SNP) within a gene encoding said mutant huntingtin protein located at a site distinct from the expanded CAG region mutation within the htt gene encoding the mutant huntingtin protein. |
地址 |
Boston MA US |